# BENDAMUSTINE HYDROCHLORIDE
> **ANDA210410** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2018-11-13
## Drug
- **FDA Application Number:** ANDA210410
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BENDAMUSTINE HYDROCHLORIDE
- **Generic name:** Bendamustine Hydrochloride
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** IV (INFUSION)
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** FRESENIUS KABI USA
- **First approval:** 2018-11-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210410)
---
*MORVS · CC0 1.0*